Function of caspases in regulating apoptosis caused by erythropoietin deprivation in erythroid progenitors

被引:0
|
作者
Gregoli, PA
Bondurant, MC
机构
[1] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
关键词
D O I
10.1002/(SICI)1097-4652(199902)178:2<133::AID-JCP2>3.3.CO;2-X
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Erythropoietin (EP) is required by late stage erythroid progenitor cells to prevent apoptosis. In a previous study (Gregoli and Bondurant, 1997, Blood 90:630-640), it was shown that rapid proteolytic conversion of procaspase 3 to the fully activated enzyme occurred when erythroblasts were deprived of EP for as little as 2 h. In the present study, protein and mRNA analyses of erythroblasts indicated the presence of the proenzyme precursors of caspases 1, 2, 3, 5, 6, 7, 8, and 9. The effects of various caspase inhibitors on caspase 3 processing and on apoptosis were examined. These inhibitors were benzyloxycarbonyl (z-) and fluoromethyl-ketone (FMK) derivatives of peptides that serve as substrates for selected caspases. z-VAD-FMK, t-butoxycarbonyl-aspartate-FMK (Boc-D-FMK), and z-IETD-FMK blocked the initial cleavage of procaspase 3, while z-DEVD-FMK, z-VEID-FMK, and z-VDVAD-FMK did not block the initial cleavage but had some effect on blocking apoptosis. The peptide inhibitor z-FA-FMK, which inhibits cathepsins B and L but is not known to inhibit caspases, altered caspase 3 processing to a final 19 kDa large subunit that appeared to retain enzymatic activity. The action of z-FA-FMK in preventing the usual conversion to a 17 kDa subunit suggests the possibility that a noncaspase protease may be involved in caspase 3 processing. Studies with the peptide inhibitors and EP were done to determine the short- and long-term effectiveness of the caspase inhibitors in protecting EP-deprived cells from apoptosis. Although several of the inhibitors were effective, z-IETD-FMK was studied most extensively because of its specificity for enzymes which cleave procaspase 3 at aspartate 175 (IETD175). Large percentages of EP-deprived erythroblasts treated with z-IETD FMK appeared morphologically normal and negative by a DNA strand breakage (TUNEL) assay at 24 h (75%) compared to EP-deprived controls (10%) which were not treated with inhibitor. However, inhibitor-treated erythroid progenitors deprived of EP for 24 h and then resupplied with EP showed only a modest improvement in long-term survival compared to cells which did not receive the caspase inhibitor during the 24 h EP deprivation. Thus, white the manifestations of apoptosis were delayed in most cells by inhibiting caspase activity, the processes initiating the toss of cell viability due to EP deprivation were irreparablein the majority of the cells and eventually led to their deaths. I Cell Physiol 178:133-143, 1999. Published 1999 Wiley-iiss, Inc.dagger.
引用
收藏
页码:133 / 143
页数:11
相关论文
共 50 条
  • [41] ERYTHROID PROGENITORS IN POLYCYTHEMIA-VERA - DEMONSTRATION OF THEIR HYPERSENSITIVITY TO ERYTHROPOIETIN USING SERUM FREE CULTURES
    CASADEVALL, N
    VAINCHENKER, W
    LACOMBE, C
    VINCI, G
    CHAPMAN, J
    BRETONGORIUS, J
    VARET, B
    BLOOD, 1982, 59 (02) : 447 - 451
  • [42] Tyrosine residues of the erythropoietin receptor are dispensable for erythroid differentiation of human CD34+ progenitors
    Fichelson, S
    Chrétien, S
    Rokicka-Piotrowicz, M
    Bouhanik, S
    Gisselbrecht, S
    Mayeux, P
    Lacombe, C
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 256 (03) : 685 - 691
  • [43] Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera
    Ugo, V
    Marzac, C
    Teyssandier, I
    Larbret, F
    Lécluse, Y
    Debili, N
    Vainchenker, W
    Casadevall, N
    EXPERIMENTAL HEMATOLOGY, 2004, 32 (02) : 179 - 187
  • [44] INVITRO RESPONSIVENESS TO ERYTHROPOIETIN (EP) - CHARACTERIZATION OF MARROW ERYTHROID PROGENITORS WITH HORMONE SENSITIVITY AT THE MILLIUNIT LEVEL
    MONETTE, FC
    OUELLETTE, PL
    FALETRA, PP
    EXPERIMENTAL HEMATOLOGY, 1980, 8 : 183 - 184
  • [45] Identification of Stat proteins activated by erythropoietin in normal erythroid progenitors and in murine and human erythroleukemia.
    Chretien, S
    Verdier, F
    Varlet, P
    Gobert, S
    Devermy, E
    Billat, C
    Gisselbrecht, S
    Mayeux, P
    Lacombe, C
    BLOOD, 1996, 88 (10) : 205 - 205
  • [46] EFFECTS OF SPLENECTOMY ON SENSITIVITY TO ERYTHROPOIETIN FROM MEDULLARY LATE ERYTHROID PROGENITORS (CFU-E)
    MIDE, S
    ALIPPI, RM
    BOZZINI, C
    MEDICINA-BUENOS AIRES, 1985, 45 (04) : 354 - 355
  • [47] Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors
    van den Akker, E
    van Dijk, T
    Parren-van Amelsvoort, M
    Grossman, KS
    Schaeper, U
    Toney-Earley, K
    Waltz, SE
    Löwenberg, B
    von Lindern, M
    BLOOD, 2004, 103 (12) : 4457 - 4465
  • [48] Redundant signals are orchestrated by the erythropoietin receptor to support proliferation and differentiation of primary erythroid progenitors.
    Klingmuller, U
    Wu, H
    Hsiao, JG
    Lodish, HF
    BLOOD, 1997, 90 (10) : 2658 - 2658
  • [49] Granulocyte colony-stimulating factor and erythropoietin reduce mitochondria-dependent apoptosis of erythroid progenitors in low-risk myelodysplastic syndromes.
    Tehranchi, R
    Fadeel, B
    Forsblom, AM
    Christensson, B
    Samuelsson, J
    Howe, RB
    Zhivotovsky, B
    Hellstrom-Lindberg, E
    BLOOD, 2002, 100 (11) : 165A - 166A
  • [50] Interferon gamma delays apoptosis of mature erythroid progenitor cells in the absence of erythropoietin
    Choi, I
    Muta, K
    Wickrema, A
    Krantz, SB
    Nishimura, J
    Nawata, H
    BLOOD, 2000, 95 (12) : 3742 - 3749